Heron Therapeutics (HRTX) Reports Q3 Loss of $1.24/Share
Heron Therapeutics (NASDAQ: HRTX) reported Q3 EPS of ($1.24), versus ($0.63) reported last year.
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
Heron Therapeutics (NASDAQ: HRTX) reported Q3 EPS of ($1.24), versus ($0.63) reported last year.
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.